144 related articles for article (PubMed ID: 38280974)
1. Clustering of atoms relative to vector space in the Z-matrix coordinate system and 'graphical fingerprint' analysis of 3D pharmacophore structure.
Kızılcan DŞ; Güzel Y; Türkmenoğlu B
Mol Divers; 2024 Jan; ():. PubMed ID: 38280974
[TBL] [Abstract][Full Text] [Related]
2. Investigation of 3D pharmacophore of N-benzyl benzamide molecules of melanogenesis inhibitors using a new descriptor Klopman index: uncertainties in model.
Alp Tokat T; Türkmenoğlu B; Güzel Y; Kızılcan DŞ
J Mol Model; 2019 Jul; 25(8):247. PubMed ID: 31342175
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking and 4D-QSAR studies of metastatic cancer inhibitor thiazoles.
Türkmenoğlu B; Güzel Y
Comput Biol Chem; 2018 Oct; 76():327-337. PubMed ID: 30145406
[TBL] [Abstract][Full Text] [Related]
4. 4D-QSAR Studies Using a New Descriptor of the Klopman Index: Antibacterial Activities of Sulfone Derivatives Containing 1, 3, 4-Oxadiazole Moiety Based on MCET Model.
Guzel Y; Aslan E; Turkmenoglu B; Su EM
Curr Comput Aided Drug Des; 2018; 14(3):207-220. PubMed ID: 29756583
[TBL] [Abstract][Full Text] [Related]
5. Development of pharmacophore similarity-based quantitative activity hypothesis and its applicability domain: applied on a diverse data-set of HIV-1 integrase inhibitors.
Kumar SP; Jasrai YT; Mehta VP; Pandya HA
J Biomol Struct Dyn; 2015; 33(4):706-22. PubMed ID: 24735019
[TBL] [Abstract][Full Text] [Related]
6. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
Lee S; Barron MG
Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
[TBL] [Abstract][Full Text] [Related]
7. Exploring QSAR and pharmacophore mapping of structurally diverse selective matrix metalloproteinase-2 inhibitors.
Halder AK; Saha A; Jha T
J Pharm Pharmacol; 2013 Oct; 65(10):1541-54. PubMed ID: 24028622
[TBL] [Abstract][Full Text] [Related]
8. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
Sharma MC
Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
[TBL] [Abstract][Full Text] [Related]
9. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional holograph vector of atomic interaction field (3D-HoVAIF): a novel rotation-translation invariant 3D structure descriptor and its applications to peptides.
Tian F; Zhou P; Lv F; Song R; Li Z
J Pept Sci; 2007 Aug; 13(8):549-66. PubMed ID: 17654623
[TBL] [Abstract][Full Text] [Related]
11. Local intersection volume: a new 3D descriptor applied to develop a 3D-QSAR pharmacophore model for benzodiazepine receptor ligands.
Verli H; Albuquerque MG; Bicca de Alencastro R; Barreiro EJ
Eur J Med Chem; 2002 Mar; 37(3):219-29. PubMed ID: 11900866
[TBL] [Abstract][Full Text] [Related]
12. Four-dimensional quantitative structure-activity relationship analysis of a series of interphenylene 7-oxabicycloheptane oxazole thromboxane A2 receptor antagonists.
Albuquerque MG; Hopfinger AJ; Barreiro EJ; de Alencastro RB
J Chem Inf Comput Sci; 1998; 38(5):925-38. PubMed ID: 9770304
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
14. Comparative molecular field analysis (coMFA) study of epothilones-tubulin depolymerization inhibitors: pharmacophore development using 3D QSAR methods.
Lee KW; Briggs JM
J Comput Aided Mol Des; 2001 Jan; 15(1):41-55. PubMed ID: 11217918
[TBL] [Abstract][Full Text] [Related]
15. QSAR Modelling of Biological Activity in Cannabinoids with Quantum Similarity Combinations of Charge Fitting Schemes and 3D-QSAR.
Navarro-Acosta D; Coba-Jimenez L; Pérez-Gamboa A; Cubillan N; Vivas-Reyes R
Chem Biodivers; 2023 May; 20(5):e202201086. PubMed ID: 37029452
[TBL] [Abstract][Full Text] [Related]
16. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
Jana S; Singh SK
J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
[TBL] [Abstract][Full Text] [Related]
17. Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.
Lu S; Liu HC; Chen YD; Yuan HL; Sun SL; Gao YP; Yang P; Zhang L; Lu T
Int J Mol Sci; 2011; 12(12):8713-39. PubMed ID: 22272100
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR.
El-Hassab MAE; El-Bastawissy EE; El-Moselhy TF
J Biomol Struct Dyn; 2020 Sep; 38(15):4521-4535. PubMed ID: 31647392
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors.
Bhatt HG; Patel PK
Bioorg Med Chem Lett; 2012 Jun; 22(11):3758-65. PubMed ID: 22546667
[TBL] [Abstract][Full Text] [Related]
20. Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure.
Mahmoudi A; Butler AE; Banach M; Jamialahmadi T; Sahebkar A
Curr Probl Cardiol; 2023 Jun; 48(6):101660. PubMed ID: 36841313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
